Vericel Corp. Company Profile (NASDAQ:VCEL)

About Vericel Corp.

Vericel Corp. logoVericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment. Its autologous cell therapy products include Carticel (autologous cultured chondrocytes), which is an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: VCEL
  • CUSIP:
Key Metrics:
  • Previous Close: $2.30
  • 50 Day Moving Average: $2.22
  • 200 Day Moving Average: $2.80
  • 52-Week Range: $1.69 - $6.69
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.52
  • P/E Growth: 0.00
  • Market Cap: $49.30M
  • Outstanding Shares: 21,434,000
  • Beta: 2.35
Additional Links:
Companies Related to Vericel Corp.:

Analyst Ratings

Consensus Ratings for Vericel Corp. (NASDAQ:VCEL) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $12.00 (421.74% upside)

Analysts' Ratings History for Vericel Corp. (NASDAQ:VCEL)
Show:
DateFirmActionRatingPrice TargetDetails
4/5/2016Needham & Company LLCReiterated RatingBuy$12.00View Rating Details
4/5/2016Bank of America Corp.DowngradeBuy -> NeutralView Rating Details
3/12/2016Ladenburg ThalmannReiterated RatingBuyView Rating Details
3/24/2015Maxim GroupReiterated RatingHoldView Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Vericel Corp. (NASDAQ:VCEL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016        
8/8/2016Q216($0.16)($0.21)$15.05 million$12.80 millionViewN/AView Earnings Details
5/10/2016Q116($0.25)($0.08)$11.60 million$14.10 millionViewListenView Earnings Details
3/14/2016Q415($0.15)($0.28)$17.36 million$15.40 millionViewListenView Earnings Details
11/13/2015Q315($0.21)($0.26)$10.50 million$11.30 millionViewListenView Earnings Details
8/12/2015Q215($0.13)($0.16)$11.31 million$13.60 millionViewListenView Earnings Details
5/14/2015Q115($0.14)($0.27)$11.10 million$10.80 millionViewListenView Earnings Details
3/23/2015Q414($0.47)($0.17)$10.70 million$14.70 millionViewListenView Earnings Details
11/13/2014Q314($0.66)($0.52)$6.73 million$9.66 millionViewN/AView Earnings Details
8/14/2014Q214($1.59)($0.94)$4.43 millionViewN/AView Earnings Details
5/15/2014Q114($0.92)($1.26)ViewN/AView Earnings Details
3/13/2014Q413($1.34)($0.97)$0.02 million$0.01 millionViewN/AView Earnings Details
11/12/2013Q3($2.02)($0.06)ViewListenView Earnings Details
5/8/2013Q1 2013($0.19)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vericel Corp. (NASDAQ:VCEL)
Current Year EPS Consensus Estimate: $-0.5 EPS
Next Year EPS Consensus Estimate: $-0.27 EPS

Dividends

Dividend History for Vericel Corp. (NASDAQ:VCEL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vericel Corp. (NASDAQ:VCEL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/28/2016Consonance Capital ManagementMajor ShareholderSell120,000$5.39$646,800.00View SEC Filing  
9/16/2014Daniel OrlandoCOOBuy9,804$2.55$25,000.20View SEC Filing  
9/16/2014Dominick ColangeloCEOBuy20,000$2.55$51,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vericel Corp. (NASDAQ:VCEL)
DateHeadline
News IconWhy BioLargo Is Hot and Why Shares May Get Hotter [SECFilings.com] (NASDAQ:VCEL)
www.digitaljournal.com - August 29 at 7:58 PM
capitalcube.com logoETF’s with exposure to Vericel Corp. : August 25, 2016 (NASDAQ:VCEL)
www.capitalcube.com - August 25 at 8:21 PM
capitalcube.com logoETF’s with exposure to Vericel Corp. : August 12, 2016 (NASDAQ:VCEL)
www.capitalcube.com - August 12 at 8:13 PM
capitalcube.com logoVericel Corp. :VCEL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:VCEL)
www.capitalcube.com - August 11 at 11:33 AM
twst.com logoVericel Corporation: Vericel Reports Second-Quarter 2016 Financial Results (NASDAQ:VCEL)
www.twst.com - August 8 at 8:18 PM
publicnow.com logoVericel Reports Second-Quarter 2016 Financial Results (NASDAQ:VCEL)
www.publicnow.com - August 8 at 8:18 PM
finance.yahoo.com logoVericel to Host Second-Quarter 2016 Earnings Webcast and Conference Call on August 8, 2016 (NASDAQ:VCEL)
finance.yahoo.com - August 1 at 7:30 AM
News IconChecking in on Stock Volatility for: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 21 at 8:27 PM
News IconHeightened Volatility Spotted on Shares of: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 19 at 8:16 PM
capitalcube.com logoETF’s with exposure to Vericel Corp. : July 19, 2016 (NASDAQ:VCEL)
www.capitalcube.com - July 19 at 1:19 PM
News IconShares Moving Down on the Week: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 17 at 7:48 AM
News IconShares Experiencing a Downtrend: Vericel Corporation (NASDAQ:VCEL) - TGP (NASDAQ:VCEL)
telanaganapress.com - July 16 at 11:15 AM
News IconVericel Corp Can't Be More Risky. Trades Sigfnicicantly Lower - Press Telegraph (NASDAQ:VCEL)
presstelegraph.com - July 16 at 11:15 AM
news.cmlviz.com logoVericel Corporation Stock Momentum Hits Weakness - CML News (NASDAQ:VCEL)
news.cmlviz.com - July 13 at 8:25 PM
News IconVericel Corporation (NASDAQ:VCEL) Shorted Shares Decreased By 48.23% - Consumer Eagle (NASDAQ:VCEL)
www.consumereagle.com - July 12 at 8:20 PM
News IconVericel Corporation (NASDAQ:VCEL) Shorted Shares Decreased By 48.23% - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 9 at 11:00 AM
finance.yahoo.com logoVericel to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference - Yahoo Finance (NASDAQ:VCEL)
finance.yahoo.com - July 6 at 8:34 PM
News IconIncreased Volatility Watch for: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 6 at 8:34 PM
publicnow.com logoVericel to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:VCEL)
www.publicnow.com - July 6 at 5:01 PM
News IconShare Volatility in Focus: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 5 at 7:41 PM
bizjournals.com logoBoston's early-stage biotech industry is growing up. Here's the proof. (NASDAQ:VCEL)
www.bizjournals.com - July 5 at 7:26 AM
News IconTracking Stock Volatility for: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 3 at 7:27 AM
News IconVericel Corporation (NASDAQ:VCEL) Sellers Covered 48.23% of Their Shorts - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - July 3 at 7:27 AM
News IconCheck on Share Volatility: Vericel Corporation (NASDAQ:VCEL) - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - June 28 at 8:00 PM
News IconVericel Corporation (NASDAQ:VCEL) Shorts Decreased by 48.23% After Short Covering - Engelwood Daily (NASDAQ:VCEL)
www.engelwooddaily.com - June 28 at 8:00 PM
News IconIs Selling Stock Like Vericel Corp After This Multiple Bottom Winning Strategy? - HNN (NASDAQ:VCEL)
hintsnewsnetwork.com - May 31 at 8:32 PM
News IconVericel Corporation (NASDAQ:VCEL) Shorts Decreased by 63.64% After Short Covering - HNN (NASDAQ:VCEL)
hintsnewsnetwork.com - May 30 at 10:08 PM
investornewswire.com logoHold Calls Count For Vericel Corporation (NASDAQ:VCEL) At 0 - Investor Newswire (NASDAQ:VCEL)
www.investornewswire.com - May 29 at 2:33 PM
capitalcube.com logoVericel Corp. :VCEL-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (NASDAQ:VCEL)
www.capitalcube.com - May 23 at 12:59 PM
publicnow.com logoVericel Reports First-Quarter 2016 Financial Results (NASDAQ:VCEL)
www.publicnow.com - May 10 at 7:48 AM
biz.yahoo.com logoVERICEL CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:VCEL)
biz.yahoo.com - May 6 at 4:17 PM
publicnow.com logoVericel to Host First-Quarter 2016 Earnings Webcast and Conference Call on May 10, 2016 (NASDAQ:VCEL)
www.publicnow.com - April 27 at 4:51 PM
biz.yahoo.com logoVERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:VCEL)
biz.yahoo.com - April 26 at 4:37 PM
publicnow.com logoVericel to Present at 15th Annual Needham Healthcare Conference (NASDAQ:VCEL)
www.publicnow.com - April 8 at 8:47 AM
feeds.reuters.com logoUPDATE 1-Vericel stem cell heart failure therapy cuts deaths -study (NASDAQ:VCEL)
feeds.reuters.com - April 4 at 2:44 PM
bizjournals.com logo​Last month’s big stock spike at Vericel cut in half by further trial data (NASDAQ:VCEL)
www.bizjournals.com - April 4 at 2:25 PM
feeds.reuters.com logoVericel stem cell therapy cuts heart failure death, hospitalization-study (NASDAQ:VCEL)
feeds.reuters.com - April 4 at 12:18 PM
publicnow.com logoResults from Vericel's Positive Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T Presented Today at ACC and Published in The Lancet (NASDAQ:VCEL)
www.publicnow.com - April 4 at 12:00 PM
feeds.benzinga.com logoVericel Reports Publication of Trial Rationale, Study Design for Phase 2b ixCELL-DCM Trial of Ixmyelocal-T for Heart Failure Due to Ischemic Dilated Cardiomyopathy (NASDAQ:VCEL)
feeds.benzinga.com - March 28 at 9:46 AM
feeds.reuters.com logoUPDATE 1-Vericel's heart drug successful in mid-stage study (NASDAQ:VCEL)
feeds.reuters.com - March 10 at 10:43 AM
feeds.reuters.com logoVericel Corp's heart drug meets main goal in mid-stage study (NASDAQ:VCEL)
feeds.reuters.com - March 10 at 9:23 AM
News IconWatch List for Traders: Transocean Ltd., Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), Vale S.A. ... - Gaining Green (press release) (registration) (blog) (NASDAQ:VCEL)
www.gaininggreen.com - February 26 at 1:55 PM
einnews.com logoVericel to Present at Canaccord Genuity Investor Conference - EIN News (press release) (NASDAQ:VCEL)
www.einnews.com - February 26 at 1:55 PM
finance.yahoo.com logoVericel to Present at Canaccord Genuity Investor Conference (NASDAQ:VCEL)
finance.yahoo.com - February 24 at 4:05 PM
finance.yahoo.com logoVericel Announces FDA Approval of Epicel HDE Supplement (NASDAQ:VCEL)
finance.yahoo.com - February 22 at 8:30 AM
investornewswire.com logoVericel Corporation (NASDAQ:VCEL) Analyst Rating Update - Investor Newswire (NASDAQ:VCEL)
www.investornewswire.com - January 23 at 8:10 PM
News IconBioLargo Closes Financing To Advance Its Novel Wound Care Products - SECFilings.com (NASDAQ:VCEL)
secfilings.com - January 21 at 1:38 PM
insidermonkey.com logoHedge Fund Sentiment Is Stagnant On Vericel Corp (VCEL) (NASDAQ:VCEL)
www.insidermonkey.com - November 25 at 6:43 AM
biz.yahoo.com logoVERICEL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:VCEL)
biz.yahoo.com - November 13 at 11:32 AM
biz.yahoo.com logoVericel Corp Earnings Call scheduled for 8:00 am ET today (NASDAQ:VCEL)
biz.yahoo.com - November 13 at 8:00 AM

Social

Vericel Corp. (NASDAQ:VCEL) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff